🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

3,067 results for “Hospital” Clear

  1. Albutein 50 g/l solución para perfusión.

    Instituto Grifols S.A.

    Subjects with cirrhosis with ACLF-1b, ACLF-2, or ACLF-3a detected either at admission or during hospitalization

    phase 3 small molecule active

    1 trial

  2. Alirocumab

    The First People's Hospital of Lianyungang

    Intracranial Atherosclerosis

    phase 3 small molecule active

    1 trial

  3. Almonertinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-small Cell Lung Cancer Metastatic

    phase 3 small molecule active

    1 trial

  4. Amlodipine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Essential Hypertension

    phase 3 small molecule active

    1 trial

  5. Amlodipine

    The First People's Hospital of Lianyungang

    Sleep Apnea Syndrome

    phase 3 small molecule active

    1 trial

  6. Anterior Capsulotomy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Obsessive-Compulsive Disorder

    phase 3 other active

    1 trial

  7. Anti-PD-1 antibody drug named Serplulimab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Locally Advanced Rectal Cancer (LARC)

    phase 3 small molecule active

    1 trial

  8. Asparaginase

    Children's Hospital of Fudan University

    Acute Myeloid Leukemia

    phase 3 small molecule active

    1 trial

  9. Astragalus Membranaceus

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Aneurysmal Subarachnoid Hemorrhage

    phase 3 small molecule active

    1 trial

  10. Atropine sulfate eye drops 0.01%

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Myopia

    phase 3 small molecule active

    1 trial

  11. Autologous Peripheral Blood Stem Cell injection

    Hospital Authority, Hong Kong

    Acute Myocardial Infarction

    phase 3 mab active

    1 trial

  12. Azacitidine Combined With Venetoclax and ATRA group

    The First People's Hospital of Lianyungang

    Acute Myeloid Leukemia

    phase 3 small molecule active

    1 trial

  13. Azathioprine

    The First People's Hospital of Lianyungang

    Myasthenia Gravis

    phase 3 small molecule completed

    1 trial

  14. BAY 1841788, TRIPTORELIN

    Ningbo Cancer Hospital

    Patients with localised prostate cancer and high-risk features of relapse (minimum 2 high-risk criteria from National Comprehensive Cancer Network (NCCN) classification)1 and with no detectable metastasis, including no evidence of pelvic lymph node metastasis on next-generation imaging (PSMA PET/CT).

    phase 3 small molecule active

    1 trial

  15. Bacillus Calmette Guerin and interferon alpha

    Hospital Authority, Hong Kong

    Carcinoma of Urinary Bladder, Superficial

    phase 3 small molecule completed

    1 trial

  16. Barley beta-glucan(3.0g)

    Hospital Authority, Hong Kong

    Overweight; Hyperlipidemia

    phase 3 other completed

    1 trial

  17. Bedaquiline (B)

    The First People's Hospital of Lianyungang

    Pulmonary Tuberculosis

    phase 3 small molecule active

    1 trial

  18. Bevacizumab

    Hospital Authority, Hong Kong

    Proliferative Diabetic Retinopathy

    phase 3 small molecule completed

    1 trial

  19. Bilateral Nucleus Accumbens DBS (Suzhou Sceneray)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Obsessive Compulsive Disorder

    phase 3 other terminated

    1 trial

  20. Bisoprolol Fumarate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Duchenne Muscular Dystrophy

    phase 3 small molecule active

    1 trial

  21. Bortezomib

    Hospital Authority, Hong Kong

    Multiple Myeloma

    phase 3 small molecule active

    1 trial

  22. Botulinum Toxin type A (intradermal / submucosal injection at pain area)

    The First People's Hospital of Lianyungang

    Trigeminal Neuralgia

    phase 3 small molecule active

    1 trial

  23. Botulinum toxin type A

    Hospital Authority, Hong Kong

    Obesity

    phase 3 small molecule active

    1 trial

  24. Brentuximab Vedotin for Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Classical Hodgkin Lymphoma

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources